Money, Money, Money: Questions of Risk, Regulation and a Whole New Investing Environment

From the 2023 TMA Distressed Investing Conference

What would it look like if regulation came to the unregulated? Would that put an end to banks efficiently offloading their distress? Paycheck Protection Program (PPP) funding, other government bailout money, and private equity (PE) money...

Lender-on-Lender Violence: Recent Trends in Dropdown and Up-Tier Transactions

From the 2023 TMA Distressed Investing Conference

What are the takeaways from recent litigation? How do minority lenders protect themselves? Does increased restructuring activity change the lender approach? These topics, and more, will be discussed with a panel of experts.


Energy Instability, Market Volatility, and Associated Risk for Investors

From the 2023 TMA Distressed Investing Conference

The next 1-3 years are going to be bumpy, with energy prices and high capital costs squeezing companies and causing a lot of problems. In this exciting session, you’ll hear from panelists who have experience in varying aspects of energy...

Deals and Steals: Consumer Spending Shifts and Impacts on Investors and Lenders

From the 2023 TMA Distressed Investing Conference

Among the many effects of the COVID-19 pandemic, shifts in consumer spending caused unprecedented volatility. Companies that were agile enough to pivot quickly seized the opportunities for growth in areas such as health and fitness, home...

Mega Trends 6.0: Back by Popular Demand

From the 2023 TMA Distressed Investing Conference

Join an esteemed group of panelists on our signature Mega Trends panel as they discuss economic factors and geopolitical trends that will impact what sectors and assets are likely to become distressed in the coming year. Topics will...

The Biotech Battalion Takes on Pharmaceuticals, Assets, and Investments

From the 2022 TMA Annual

Learn the ABCs of the biotech world, including restructuring in biotech. What is the market like for this industry, and where is the money going? Where does the FDA process fit in, and what are the unique considerations regarding the erosion of asset value? What...

Fraud and Field Examiners: Finding Benedict Arnold

From the 2022 TMA Annual

Over the last two and half years, fraud and field examiners have had to battle many obstacles directly resulting from COVID mitigation strategies, including:

  • Accounting and finance staff of clients being completely remote
  • Clients not allowing
  • ...
Life, Liberty, and the Pursuit of Talent

From the 2022 TMA Annual

Join this panel for a deep dive into the challenges—and opportunities—within the current labor/staffing market for both restructuring firms and their clients. How will immigration (or lack thereof), COVID, and Baby Boomers leaving the labor market affect...

The Unprecedented Financial Crisis of the Evergrande Group

From the 2022 TMA Annual

All eyes are on the largest property developer in China, the Evergrande Group, as offshore creditors holding bonds and notes are looking at billions of dollars in losses if they do not act to protect their interests in various jurisdictions. The preliminary...

The C-Suite Spills the (Boston) Beans

From the 2022 TMA Annual Conference

During the last few years, the insolvency industry has witnessed a tumult of financial advisory firm activity. New entrants, acquisitions, roll-ups, service expansions, investment banks, and strategy firms are moving into the classic restructuring space...